Skip to main content

World

International reporting with regional context and cross-border impact.

World

Briefing: Eli Lilly’s ‘triple-G’ shows potency, raises concerns

Strategic angle: Eli Lilly's 'triple-G' drug shows potency, In-vivo CAR-T inches toward clinical reality, and more in today's Readout newsletter.

World

Briefing: ‘They’re living on deathbeds’: As India expands coal power, a mining town suffers

Strategic angle: The Examination explores the impact of coal power expansion on a mining town in India.

World

Briefing: The BMW i3 Almost Got The iX3's Vertical Kidney Grille

Strategic angle: BMW's design director said it would have 'looked too retro.'

World

Briefing: World trade growth set to slow to 1.9% this year, Iran war may weigh more, says WTO

Strategic angle: The World Trade Organization predicts a slowdown in global trade growth amid geopolitical tensions.

World

Briefing: Consensus Board Game

Strategic angle: Exploring the innovative Consensus Board Game that merges strategy with technology.

World

Briefing: ‘Armageddon scenario’ for gas markets as Qatar hit by missiles

Strategic angle: Traders and analysts warn of lasting disruption after damage to facility that supplies a fifth of the world’s LNG.

World

Briefing: The SAVE Act faces long odds in the Senate. GOP-led states are picking up the cause

Strategic angle: Several Republican-led states are passing their own versions of the SAVE America Act, Trump-backed legislation that would introduce new proof-of-citizenship requirements to register to vote.

World

Briefing: Cornell Students Are Making a Bold Case for Nuclear Energy on Campus

Strategic angle: Students advocate for the benefits of nuclear energy in a sustainable future.

World

Briefing: Inside the Centre for Islamic Civilization: A new hub for heritage and research

Strategic angle: The complex brings together manuscripts, research facilities and interactive exhibitions, offering public access to Islamic heritage through education, technology and international collaboration.

World

Briefing: The Mercedes-AMG CLE 63 Is Coming With 646 Horsepower: Report

Strategic angle: U.S. dealers saw the potent coupe and the AMG G63 Cabriolet.

World

Briefing: Uber to invest up to $1.25 billion in EV maker Rivian in deal to launch 50,000 robotaxis

Strategic angle: Uber plans to invest in Rivian to deploy a fleet of autonomous robotaxis by 2031.

World

Briefing: Clearing the Air: How UNM’s Radiation Exposure Screening and Education Program (RESEP) Helps the Uranium Miners of New Mexico

Strategic angle: UNM's RESEP provides essential support for uranium miners facing radiation exposure.

World

Afghanistan accuses Pakistan of killing at least four civilians in Kabul strike

The Taliban government claims airstrikes by Pakistan's military targeted a drug rehabilitation hospital, resulting in civilian casualties.

World

Briefing: Former counter-terrorism head investigated by FBI over alleged leaks

Strategic angle: The former counter-terrorism head resigned on Tuesday over the war with Iran, saying the country posed 'no imminent threat' to the US.

World

Briefing: This Utility Company Trading In A Buy Zone Offers A Bright Future

Strategic angle: This Utility Company Trading In A Buy Zone Offers A Bright Future

World

Northshore Mining fined $19,000 for multiple waste water violations

The company faces penalties for failing to comply with environmental regulations.

World

Briefing: Lithium Americas: Q4 Earnings Snapshot

Strategic angle: A look at the financial performance of Lithium Americas in the fourth quarter.

World

Briefing: EU leaders balk at joining Middle East fight, grapple with high energy prices

Strategic angle: EU leaders are hesitant to engage in the Middle East conflict while facing rising energy costs.

World

Briefing: UK–Nigeria relations in focus as London hosts Tinubu

Strategic angle: Britain has rolled out the red carpet for Nigerian President Bola Tinubu, marking the first state visit by a Nigerian leader in 37 years.

World

Briefing: STAT+: Six drugmakers, six months: Charting the FDA’s course in the post-Prasad era

Strategic angle: Will the FDA’s regulatory policies, particularly for rare-disease drugs, shift in the wake of Vinay Prasad’s imminent departure?